Sunday, 29 March 2020

Australia News

  • AusBiotech appoints new board member

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: AusBiotech announced the appointment of Mr Lawrence Gozlan as a non-executive director, bringing to the Board global capital markets experience and specialist knowledge in life ...Read more

  • FDA agrees to Mesoblast MPC supply in the US

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Singapore: Mesoblast announced that US FDA is in agreement for the supply of its proprietary Mesenchymal Precursor Cells (MPCs) for clinical trials in the US under Investigational New Drug...Read more

  • Academy discusses future of Australian science

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2012

    Singapore: The Australian Academy of Science's recently established Early-Mid Career Researcher Forum held its first national meeting on September 24 in order to discuss the future of Austr...Read more

  • Asia vaccine strategists call for collaboration

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply for public health, and stronger partnership between international pl...Read more

  • Lose weight and treat diabetes at the same time

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Sep, 2012

    Singapore: Doctors at St Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney are now offering EndoBarrier Therapy, a revolutionary, non-surgical, non-pharmaceutical alternati...Read more

  • Transgene out-licenses TG1042 to Ascend Pharma

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: French biotech firm Transgene SA has granted Ascend Biopharmaceuticals, an emerging privately-held Australian immunotherapy company, a license to develop and commercialize TG1042...Read more

  • NeuClone, Serum Institute join hands

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    Singapore: Sydney-based biotechnology firm, NeuClone has signed a major licensing agreement and joint development partnership with The Serum Institute of India. The deal will cover the manu...Read more

  • Victoria is on mission to tap the Indian market

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Hyderabad: BioAsia 2013, which was held recently from January 28-30, 2013, at Hyderabad, India, saw participation from 500 representatives from 45 countries. One-of-the-delegations that att...Read more

  • Muted growth for Australia in 2011

    Australia |  Analysis | By Piyusha Chatterjee | 0 Comment | 29 May, 2012

    Despite concerns over the operating environment in Australia and predictions of receding demand in the domestic market, the bioscience industry in the country is reflecting bullish sentimen...Read more

  • New drug delivery polymer to treat cancer

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: Dr Lingxue Kong and research colleagues at Deakin University in Melbourne, Australia, have combined two polymers to provide a less painful oral method of administering cancer-fig...Read more

  • Study visualizes link between gluten and immune system

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 12 Oct, 2012

    Singapore: A link between gluten and the immune system has literally been visualized in new research published in the scientific journal Immunity. The discovery is the collaborative work of...Read more

  • Phylogica, Cubist evaluate antimicrobial phylomers

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2013

    Singapore: Phylogica is collaborating with Cubist Pharmaceuticals in order to evaluate several of its antimicrobial Phylomers in models of multi-drug resistant bacterial infections. Dr Paul...Read more

  • Kevin Buchi joins Benitec board

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Apr, 2013

    Singapore: Benitec Biopharma appointed Mr Kevin Buchi to its board of directors. Mr Buchi served as CEO of Cephalon, through its $6.8 billion acquisition by Teva Pharmaceutical Industries i...Read more

  • Osiris successfully defends patent challenge in Australia

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Singapore: Osiris Therapeutics, a Columbia-based company focused on developing and marketing stem cell products to treat serious medical conditions, has successfully defended a patent chall...Read more

  • Gene discovery to avoid fatal baby disease

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    Singapore: One of the genes which causes a muscle disease so severe that newborn babies rarely survive beyond a few days has been discovered by an international team of scientists, coordina...Read more

  • Aussie firm gets TGA approval for pancreatic cancer drug

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

    Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Goods Administration (TGA) approval for ABRAXANE (nanoparticle albumin-bo...Read more

  • AIDS 2014: Bill Clinton urges efficient routes for HIV treatment

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2014

    Singapore: Former US President Bill Clinton addressed delegates at AIDS 2014, 20th International AIDS Conference, that finding more economically efficient ways to respond to HIV is vital to...Read more

  • Starpharma, Makhteshim enter agro collaboration

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: Starpharma Holdings and Makhteshim Agan Group announced a collaboration program that will see Starpharma's Priostar dendrimer technology applied to novel crop protection formula...Read more



Survey Box

Are women in the industry getting the required recognition for their efforts?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls